Table 3.
Baseline and Follow-up Assessments
| Assessment | Collection Method | Baseline | 3-Month Follow-up | 6-Month Follow-up |
|---|---|---|---|---|
| Executive function | Direct measurement | X | X | X |
| Trail Making Test Parts A and B (TMTA/B) | ||||
| Stroop Test | ||||
| Digit Symbol Substitution Test | ||||
| Global cognitive function | Direct measurement | X | X | X |
| MoCA | ||||
| Auditory/Verbal Learning Test | Direct measurement | X | X | X |
| Physical Frailty Phenotype | Direct measurement | X | X | X |
| Self-reported Quality of Life | Validated questionnaire | X | X | X |
| Lower-extremity function | Direct measurement | X | X | X |
| Short Physical Performance Battery | ||||
| Functional Status: | Self-report | X | X | X |
| IADL/ADL | ||||
| PROMIS-29 short-form profile | Validated self-report instrument | X | X | X |
| Anxiety, depression, fatigue, pain, perceived function, sleep disturbance, and participation in social roles/activities | ||||
| Demographics | Self-report and abstraction | X | ||
| Working status | Self-report | X | X | X |
| Charlson Comorbidity Index for ESKD | Self-report and abstraction | X | X | X |
| Health behaviors (Smoking status, alcohol intake, and illicit drug use) | Self-report and abstraction | X | X | X |
| Medical factors (pre-dialysis factors) | Chart abstraction | X | ||
| Clinical measures | Chart abstraction | X | ||
| Amputation | Self-report and abstraction | X | X | X |
| Dialysis factors | Chart abstraction | X | X | X |